Literature DB >> 14722647

Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets.

T Lau1, P-O Carlsson, P S Leung.   

Abstract

AIMS/HYPOTHESIS: A local angiotensin-generating system has been found in the exocrine pancreas. This study aimed, primarily, to investigate the existence of a local angiotensin-generating system in the pancreatic islets and, secondly, to elucidate its role in regulating insulin secretion.
METHODS: Real-time RT-PCR and western blot were used to investigate if angiotensin-generating components are present in the mouse pancreatic islets, which are subject to regulation by islet transplantation. The localisation of AT1-receptors in islets was investigated by immunohistochemistry. Batch-type incubations of isolated islets were applied for studying the influence of angiotensin II on the glucose-stimulated insulin release, glucose oxidation and (pro)insulin, and total protein biosynthesis.
RESULTS: Major components, namely angiotensinogen, ACE, AT1- and AT2-receptors, were expressed in endogenous islets. AT1-receptors were localised to pancreatic beta cells. Exposure of the isolated islets to angiotensin II induced a dose-dependent inhibition of glucose-stimulated insulin release and inhibited (pro)insulin biosynthesis. This inhibitory action was fully preventable by pretreatment of the islets with losartan, an AT1-receptor antagonist. We also investigated if the expression of these components was changed after islet transplantation. Notably, a markedly increased expression of mRNA for the AT1-receptor was observed in islets retrieved from 4-week-old syngeneic islet transplants, a finding that was confirmed at the protein level. CONCLUSION/
INTERPRETATION: These data indicate the existence of an islet angiotensin-generating system of potential importance in the physiological regulation of glucose-induced insulin secretion, thus diabetes mellitus. The increased expression of the AT1-receptor in islet transplants could have relevance to islet-graft function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14722647     DOI: 10.1007/s00125-003-1295-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  45 in total

1.  Local blood flow regulation in transplanted rat pancreatic islets: influence of adenosine, angiotensin II, and nitric oxide inhibition.

Authors:  R Olsson; L Jansson; A Andersson; P O Carlsson
Journal:  Transplantation       Date:  2000-07-27       Impact factor: 4.939

2.  Low revascularization of experimentally transplanted human pancreatic islets.

Authors:  Per-Ola Carlsson; Fredrik Palm; Göran Mattsson
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

3.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

4.  Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells.

Authors:  N Jaiswal; D I Diz; E A Tallant; M C Khosla; C M Ferrario
Journal:  Am J Physiol       Date:  1991-05

5.  Regulated expression of pancreatic renin-angiotensin system in experimental pancreatitis.

Authors:  P S Leung; W P Chan; R Nobiling
Journal:  Mol Cell Endocrinol       Date:  2000-08-30       Impact factor: 4.102

6.  Activation of local renin-angiotensin system by chronic hypoxia in rat pancreas.

Authors:  W P Chan; M L Fung; R Nobiling; P S Leung
Journal:  Mol Cell Endocrinol       Date:  2000-02-25       Impact factor: 4.102

7.  Postnatal hypoxemia increases angiotensin II sensitivity and up-regulates AT1a angiotensin receptors in rat carotid body chemoreceptors.

Authors:  S Y Lam; X Dong; Y Chen; P S Leung
Journal:  J Endocrinol       Date:  2002-05       Impact factor: 4.286

8.  GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice.

Authors:  Z Wang; H Gleichmann
Journal:  Diabetes       Date:  1998-01       Impact factor: 9.461

9.  Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.

Authors:  E A Ryan; J R Lakey; R V Rajotte; G S Korbutt; T Kin; S Imes; A Rabinovitch; J F Elliott; D Bigam; N M Kneteman; G L Warnock; I Larsen; A M Shapiro
Journal:  Diabetes       Date:  2001-04       Impact factor: 9.461

Review 10.  Levels of angiotensin and molecular biology of the tissue renin angiotensin systems.

Authors:  M I Phillips; E A Speakman; B Kimura
Journal:  Regul Pept       Date:  1993-01-22
View more
  66 in total

Review 1.  The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes.

Authors:  Anand Vaidya; Jonathan S Williams
Journal:  Metabolism       Date:  2011-11-09       Impact factor: 8.694

2.  Glucagon increase after chronic AT1 blockade is more likely related to an indirect leptin-dependent than to a pancreatic α-cell-dependent mechanism.

Authors:  Martin Mildner; Helge Müller-Fielitz; Ines Stölting; Olaf Jöhren; Muscha Steckelings; Walter Raasch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-31       Impact factor: 3.000

3.  Delta-like 1 homolog in Capra hircus: molecular characteristics, expression pattern and phylogeny.

Authors:  Jiangtao Hu; Wei Zhao; Siyuan Zhan; Ping Xiao; Jingxuan Zhou; Linjie Wang; Li Li; Hongping Zhang; Lili Niu; Tao Zhong
Journal:  Mol Biol Rep       Date:  2016-04-23       Impact factor: 2.316

4.  ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice.

Authors:  Robin Shoemaker; Frederique Yiannikouris; Sean Thatcher; Lisa Cassis
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-08-04       Impact factor: 4.310

5.  Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice.

Authors:  Ming-Jia Niu; Jin-Kui Yang; Shan-Shan Lin; Xiu-Juan Ji; Li-Min Guo
Journal:  Endocrine       Date:  2008-10-28       Impact factor: 3.633

6.  Modulation of hypovitaminosis D-induced islet dysfunction and insulin resistance through direct suppression of the pancreatic islet renin-angiotensin system in mice.

Authors:  Q Cheng; B J Boucher; P S Leung
Journal:  Diabetologia       Date:  2012-12-19       Impact factor: 10.122

Review 7.  The renin angiotensin aldosterone system and insulin resistance in humans.

Authors:  Patricia C Underwood; Gail K Adler
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

8.  Renal dysfunction, metabolic syndrome and cardiovascular disease mortality.

Authors:  David Martins; Chizobam Ani; Deyu Pan; Omolola Ogunyemi; Keith Norris
Journal:  J Nutr Metab       Date:  2010-03-24

9.  Phosphodiesterase 5 inhibition improves beta-cell function in metabolic syndrome.

Authors:  Kevin D Hill; Aaron W Eckhauser; Annis Marney; Nancy J Brown
Journal:  Diabetes Care       Date:  2009-02-05       Impact factor: 19.112

Review 10.  The sweeter side of ACE2: physiological evidence for a role in diabetes.

Authors:  Sharell M Bindom; Eric Lazartigues
Journal:  Mol Cell Endocrinol       Date:  2008-10-01       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.